Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 606

    1.

    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience.

    Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH.

    J Clin Oncol. 2009 Nov 16. [Epub ahead of print]PMID: 19917862 [PubMed - as supplied by publisher]Related articles

    2.

    Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.

    Chua TC, Liauw W, Saxena A, Chu F, Glenn D, Chai A, Morris DL.

    Liver Int. 2009 Nov 13. [Epub ahead of print]PMID: 19912531 [PubMed - as supplied by publisher]Related articles

    3.

    Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer.

    Pourgholami MH, Szwajcer M, Chin M, Liauw W, Seef J, Galettis P, Morris DL, Links M.

    Cancer Chemother Pharmacol. 2009 Nov 11. [Epub ahead of print]PMID: 19904538 [PubMed - as supplied by publisher]Related articles

    4.

    Urokinase plasminogen activator system as a potential target for cancer therapy.

    Mekkawy AH, Morris DL, Pourgholami MH.

    Future Oncol. 2009 Nov;5(9):1487-99.PMID: 19903074 [PubMed - in process]Related articles

    5.

    Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option.

    Saxena A, Bester L, Chua TC, Chu FC, Morris DL.

    Ann Surg Oncol. 2009 Oct 30. [Epub ahead of print]PMID: 19876691 [PubMed - as supplied by publisher]Related articles

    6.

    Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases.

    Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL.

    Ann Surg Oncol. 2009 Oct 24. [Epub ahead of print]PMID: 19856028 [PubMed - as supplied by publisher]Related articles

    7.

    In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.

    Chua TC, Akther J, Yao P, Morris DL.

    Anticancer Res. 2009 Oct;29(10):4051-5.PMID: 19846950 [PubMed - in process]Related articles

    8.

    Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole.

    Chu SW, Badar S, Morris DL, Pourgholami MH.

    Anticancer Res. 2009 Oct;29(10):3791-6.PMID: 19846910 [PubMed - in process]Related articles

    9.

    Morbidity and Mortality Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy at a Single Tertiary Institution: Towards a New Perspective of This Treatment.

    Chua TC, Saxena A, Schellekens JF, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL.

    Ann Surg. 2009 Oct 15. [Epub ahead of print]PMID: 19838105 [PubMed - as supplied by publisher]Related articles

    10.

    Impact of Tumor Angiogenesis in Peritoneal Mesothelioma After Radical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.

    Chua TC, Yao P, Akther J, Morris DL.

    Pathol Oncol Res. 2009 Oct 1. [Epub ahead of print]PMID: 19789996 [PubMed - as supplied by publisher]Related articles

    11.

    Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases.

    Ding JH, Chua TC, Glenn D, Morris DL.

    Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):1051-3. Epub 2009 Sep 18.PMID: 19767303 [PubMed - in process]Related articlesFree article

    12.

    A Critical Evaluation of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Peritoneal Carcinomatosis.

    Saxena A, Yan TD, Morris DL.

    World J Surg. 2009 Sep 16. [Epub ahead of print]PMID: 19760317 [PubMed - as supplied by publisher]Related articles

    13.

    Recent advances in understanding leptin signaling and leptin resistance.

    Morris DL, Rui L.

    Am J Physiol Endocrinol Metab. 2009 Dec;297(6):E1247-59. Epub 2009 Sep 1.PMID: 19724019 [PubMed - in process]Related articles

    14.

    Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma.

    Ng KM, Yan TD, Black D, Chu FC, Morris DL.

    HPB (Oxford). 2009;11(4):311-20.PMID: 19718358 [PubMed - in process]Related articles

    15.

    Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

    Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL.

    J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45. Epub 2009 Aug 23. Review.PMID: 19701772 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis.

    Cao CQ, Yan TD, Liauw W, Morris DL.

    J Surg Oncol. 2009 Dec 1;100(7):529-33.PMID: 19697395 [PubMed - in process]Related articles

    17.

    A comprehensive review of prehospital and in-hospital delay times in acute stroke care.

    Evenson KR, Foraker RE, Morris DL, Rosamond WD.

    Int J Stroke. 2009 Jun;4(3):187-99. Review.PMID: 19659821 [PubMed - indexed for MEDLINE]Related articles

    18.

    Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.

    Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J.

    Ann Surg Oncol. 2009 Oct;16(10):2765-70. Epub 2009 Jul 30.PMID: 19641972 [PubMed - in process]Related articles

    19.

    Pseudomyxoma peritonei: a need to establish evidence-based standard of care--is this the right trial?

    Chua TC, Al-Mohaimeed K, Liauw W, Morris DL.

    Ann Surg Oncol. 2009 Oct;16(10):2675-7. Epub 2009 Jul 29. No abstract available. PMID: 19639367 [PubMed - in process]Related articlesFree article

    20.

    Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.

    Chua TC, Yan TD, Zhao J, Morris DL.

    Eur J Surg Oncol. 2009 Dec;35(12):1299-305. Epub 2009 Jul 24.PMID: 19632081 [PubMed - in process]Related articles

    21.

    Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures.

    Saxena A, Yan TD, Morris DL.

    Eur J Surg Oncol. 2009 Jul 15. [Epub ahead of print]PMID: 19615849 [PubMed - as supplied by publisher]Related articles

    22.

    Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.

    Chua TC, Liauw W, Robertson G, Morris DL.

    Gynecol Oncol. 2009 Oct;115(1):166-8; author reply 168-9. Epub 2009 Jul 14. No abstract available. PMID: 19604568 [PubMed - indexed for MEDLINE]Related articles

    23.

    New treatments and outcomes in peritoneal carcinomatosis.

    Chua TC, Liauw W, Morris DL.

    Med J Aust. 2009 Jul 6;191(1):3-4. No abstract available. PMID: 19580525 [PubMed - indexed for MEDLINE]Related articles

    24.

    The St George Hospital Peritoneal Surface Malignancy Program--where are we now?

    Chua TC, Liauw W, Morris DL.

    ANZ J Surg. 2009 Jun;79(6):416-8. No abstract available. PMID: 19566860 [PubMed - indexed for MEDLINE]Related articles

    25.

    Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?

    Adie S, Yip C, Chu F, Morris DL.

    ANZ J Surg. 2009 May;79(5):358-61.PMID: 19566517 [PubMed - indexed for MEDLINE]Related articles

    26.

    Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.

    Chua TC, Koh JL, Yan TD, Liauw W, Morris DL.

    J Surg Oncol. 2009 Aug 1;100(2):139-43.PMID: 19544356 [PubMed - indexed for MEDLINE]Related articles

    27.

    Book Review.

    Morris DL.

    J Alzheimers Dis. 2009 Jun 19. [Epub ahead of print] No abstract available. PMID: 19542609 [PubMed - as supplied by publisher]Related articles

    28.

    SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins.

    Morris DL, Cho KW, Zhou Y, Rui L.

    Diabetes. 2009 Sep;58(9):2039-47. Epub 2009 Jun 19.PMID: 19542202 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.

    Lasala JM, Cox DA, Morris DL, Breall JA, Mahoney PD, Horwitz PA, Shaw D, Hood KL, Mandinov L, Dawkins KD.

    Am J Cardiol. 2009 Jun 15;103(12):1663-71. Epub 2009 Apr 16.PMID: 19539073 [PubMed - indexed for MEDLINE]Related articles

    30.

    Quality of life of adult patients with sickle cell disease.

    Mann-Jiles V, Morris DL.

    J Am Acad Nurse Pract. 2009 Jun;21(6):340-9.PMID: 19527313 [PubMed - indexed for MEDLINE]Related articles

    32.

    A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.

    Cao C, Yan TD, Black D, Morris DL.

    Ann Surg Oncol. 2009 Aug;16(8):2152-65. Epub 2009 May 12. Review.PMID: 19434455 [PubMed - indexed for MEDLINE]Related articles

    33.

    Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis.

    Chua TC, Yan TD, Ng KM, Zhao J, Morris DL.

    World J Surg. 2009 Jul;33(7):1488-94.PMID: 19412567 [PubMed - indexed for MEDLINE]Related articles

    34.

    Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures.

    Saxena A, Yan TD, Chua TC, Fransi S, Almohaimeed K, Ahmed S, Morris DL.

    Ann Surg Oncol. 2009 Aug;16(8):2195-203. Epub 2009 May 1.PMID: 19408046 [PubMed - indexed for MEDLINE]Related articles

    35.

    Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE.

    Morris DL, Graham RR, Erwig LP, Gaffney PM, Moser KL, Behrens TW, Vyse TJ, Graham DS.

    Genes Immun. 2009 Jul;10(5):404-13. Epub 2009 Apr 30.PMID: 19404301 [PubMed - indexed for MEDLINE]Related articles

    36.

    Differential Expression of Ki-67 and Sex Steroid Hormone Receptors Between Genders in Peritoneal Mesothelioma.

    Chua TC, Yao P, Akther J, Young L, Bao S, Samaraweera U, Yan TD, Morris DL.

    Pathol Oncol Res. 2009 Apr 29. [Epub ahead of print]PMID: 19401830 [PubMed - as supplied by publisher]Related articles

    37.

    Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.

    Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL.

    Ann Surg Oncol. 2009 Jul;16(7):1903-11. Epub 2009 Apr 23.PMID: 19387742 [PubMed - indexed for MEDLINE]Related articles

    38.

    The heritability and genetics of complement C3 expression in UK SLE families.

    Rhodes B, Hunnangkul S, Morris DL, Hsaio LC, Graham DS, Nitsch D, Whittaker JC, Vyse TJ.

    Genes Immun. 2009 Jul;10(5):525-30. Epub 2009 Apr 23.PMID: 19387462 [PubMed - indexed for MEDLINE]Related articles

    39.

    Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.

    Chua TC, Liauw W, Robertson G, Chia WK, Soo KC, Alobaid A, Al-Mohaimeed K, Morris DL.

    Gynecol Oncol. 2009 Jul;114(1):137-9; author reply 139. Epub 2009 Apr 14. No abstract available. PMID: 19368962 [PubMed - indexed for MEDLINE]Related articles

    40.

    Radiofrequency ablation of lung tumors: feasibility and safety.

    Zhu JC, Yan TD, Glenn D, Morris DL.

    Ann Thorac Surg. 2009 Apr;87(4):1023-8.PMID: 19324122 [PubMed - indexed for MEDLINE]Related articles

    41.

    Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole.

    Pourgholami MH, Cai ZY, Wang L, Badar S, Links M, Morris DL.

    Cancer Invest. 2009 Feb;27(2):171-7.PMID: 19235589 [PubMed - indexed for MEDLINE]Related articles

    42.

    Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

    Chua TC, Yan TD, Morris DL.

    Can J Surg. 2009 Feb;52(1):59-64. Review.PMID: 19234654 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.

    Ghous Z, Akhter J, Pourgholami MH, Morris DL.

    Anticancer Res. 2008 Nov-Dec;28(6A):3757-61.PMID: 19189661 [PubMed - indexed for MEDLINE]Related articles

    44.

    Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei.

    Chua TC, Yan TD, Yap ZL, Horton MD, Fermanis GG, Morris DL.

    J Surg Oncol. 2009 Apr 1;99(5):292-5.PMID: 19180588 [PubMed - indexed for MEDLINE]Related articles

    45.

    Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma.

    Ng KM, Niu R, Yan TD, Zhao J, McKay E, Chu FC, Morris DL.

    HPB (Oxford). 2008;10(6):388-95.PMID: 19088923 [PubMed - in process]Related articlesFree article

    46.

    Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.

    Koh JL, Yan TD, Glenn D, Morris DL.

    Ann Surg Oncol. 2009 Feb;16(2):327-33. Epub 2008 Dec 3.PMID: 19050972 [PubMed - indexed for MEDLINE]Related articles

    47.

    Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit[n]uril.

    Zhao Y, Buck DP, Morris DL, Pourgholami MH, Day AI, Collins JG.

    Org Biomol Chem. 2008 Dec 21;6(24):4509-15. Epub 2008 Nov 6.PMID: 19039358 [PubMed - indexed for MEDLINE]Related articles

    48.

    Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.

    Pourgholami MH, Wangoo KT, Morris DL.

    Anticancer Res. 2008 Sep-Oct;28(5A):2775-9.PMID: 19035309 [PubMed - indexed for MEDLINE]Related articles

    49.

    Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.

    Chua TC, Yan TD, Morris DL.

    J Surg Oncol. 2009 Feb 1;99(2):109-13.PMID: 19016259 [PubMed - indexed for MEDLINE]Related articles

    50.

    Re: An evidence-based approach: Sugarbaker protocol and pseudomyxoma peritonei of appendiceal origin.

    Morris DL.

    ANZ J Surg. 2008 Nov;78(11):1043; author reply 1043. No abstract available. PMID: 18959716 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...